arrow
A

Allyn T. Londregan

university of california berkeley
H指数:22
被引数:1,510

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Discovery of High-Affinity Small-Molecule Binders of the Epigenetic Reader YEATS4
2022-12-2311
PRE
Discovery of Ervogastat (PF-06865571): A Potent and Selective Inhibitor of Diacylglycerol Acyltransferase 2 for the Treatment of Non-alcoholic Steatohepatitis
2022-11-0214
PRE
Small Molecule Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors: Hit to Lead Optimization of Systemic Agents
2018-06-0742
PREAI
Discovery of a Novel Small-Molecule Modulator of C-X-C Chemokine Receptor Type 7 as a Treatment for Cardiac Fibrosis
2018-04-0822
PREAI
Liver-Targeted Small-Molecule Inhibitors of Proprotein Convertase Subtilisin/Kexin Type 9 Synthesis
2017-11-2438
PREAI
Discovery of an in Vivo Tool to Establish Proof-of-Concept for MAP4K4-Based Antidiabetic Treatment
2015-10-0638
OAAI
Discovery of Selective Small Molecule Inhibitors of Monoacylglycerol Acyltransferase 3
2015-09-0816
PREAI
Discovery of PF-5190457, a Potent, Selective, and Orally Bioavailable Ghrelin Receptor Inverse Agonist Clinical Candidate
2014-02-2463
OAAI
Identification of Tetrahydropyrido[4,3-d]pyrimidine Amides as a New Class of Orally Bioavailable TGR5 Agonists

鉴定四氢吡啶并 [4,3-d] 嘧啶酰胺作为一类新的口服生物可利用的TGR5激动剂

2012-11-0947
OA